Portfolio → TheraB Medical
TheraB Medical
TheraB Medical developed SnugLit, a wearable phototherapy solution that lets newborns receive jaundice treatment while remaining in their caregiver's arms, preserving bonding without compromising care. A conservative QALY analysis found roughly $13,000 of societal health benefit per dollar invested. Acquired by Natus Medical.
Visit TheraB MedicalMore from the portfolio
Bloomlife
Bloomlife is modernizing maternal care with a remote monitoring platform for high-risk pregnancies. It offers reimbursable monitoring for conditions such as hypertension and diabetes and is preparing to launch the first FDA-cleared at-home fetal non-stress test, built on proprietary biosignal technology for Medicaid, rural, and underserved populations.
CRISPR QC
CRISPR QC brings real-time quality control into gene-editing workflows, turning a slow, opaque 'black box' process into one that is measurable, predictable, and dramatically faster. Its SaaS platform and chip make CRISPR safe and scalable for therapeutic applications.
NEXT Life Sciences
NEXT Life Sciences is developing Plan A, a long-acting, non-hormonal, fully reversible male contraceptive advancing through clinical development. The platform is expanding into additional reproductive-health programs, including endometriosis, targeting some of the largest and most underserved markets in healthcare.